Ca2+-dependent interaction of S100A1 with F,-ATPase leads to an increased ATP content in cardiomyocytes

Molecular and Cellular Biology

Volumn 27, Issue 12, 2007, Pages 4365-4373

  Boerries, Melanie ^a,b   Most, Patrick ^c,d   Gledhill, Jonathan R ^e   Walker, John E ^e   Katus, Hugo A ^d   Koch, Walter J ^c   Aebi, Ueli ^a   Schoenenberger, Cora Ann ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; PROTEIN S 100; PROTEIN S 100A1; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG; CALCIUM; GLUTATHIONE TRANSFERASE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LUCIFERASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; S100A1 PROTEIN;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; HEART LEFT VENTRICLE MUSCLE; HEART MITOCHONDRION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; IMMUNOELECTRON MICROSCOPY; KNOCKOUT MOUSE; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; ADENOVIRUS; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; CYTOLOGY; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HEART MUSCLE CELL; HEART VENTRICLE; ISOLATION AND PURIFICATION; METABOLISM; MOUSE MUTANT; REPORTER GENE; RNA INTERFERENCE; ULTRASTRUCTURE;

MUS; RATTUS;

ADENOSINE TRIPHOSPHATE; ADENOVIRIDAE; ANIMALS; CALCIUM; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, REPORTER; GLUTATHIONE TRANSFERASE; GREEN FLUORESCENT PROTEINS; HEART VENTRICLES; LUCIFERASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; PROTON-TRANSLOCATING ATPASES; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; S100 PROTEINS;

EID: 34250201078     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02045-06     Document Type: Article

References (32)

1. Balaban, R. S. 2002. Cardiac energy metabolism homeostasis: role of cytosolic calcium. J. Mol. Cell. Cardiol. 34:1259-1271.
2. Bosetti, F., G. Yu, R. Zucchi, S. Ronca-Testoni, and G. Solaini. 2000. Myocardial ischemic preconditioning and milochondrial FlF0-ATPase activity. Mol. Cell. Biochem. 215:31-37.
3. Cadenas, S., and M. D. Brand. 2000. Effects of magnesium and nucleotides on the proton conductance of rat skeletal-muscle milochondria. Biochem. J. 348:209-213.
4. Donato, R. 2003. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60:540-551.
5. Du, X. J., T. J. Cole, N. Tenis, X. M. Gao, F. Kontgen, B. E. Kemp, and J. Heierhorst. 2002. Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice. Mol. Cell. Biol. 22:2821-2829.
6. Duchen, M. R. 2004. Roles of mitochondria in health and disease. Diabetes 53(Suppl. 1):S96-S102.
7. Florholmen, G., V. Aas, A. C. Rustan, P. K. Lunde, N. Strauinann, H. Eid. A. Odegaard, H. Dishington, K. B. Andersson, and G. Christensen. 2004. Leukemia inhibitory factor reduces contractile function and induces alterations in energy metabolism in isolated cardiomyocytes. J. Mol. Cell. Cardiol. 37:1183-1193.
8. Haimoto, H., and K. Kato. 1987. S100a0 (alpha alpha) protein, a calcium-binding protein, is localized in the slow-twitch muscle fiber. J. Neurochem. 48:917-923.
9. Heizmann, C. W., and J. A. Cox. 1998. New perspectives on S100 proteins: a multi-functional Ca(2+)-. Zn(2+)- and Cu(2+)-binding protein family. Biometals 11:383-397.
10. Huss, J. M., and D. P. Kelly. 2005. Milochondrial energy metabolism in heart failure: a question of balance. J. Clin. Investig. 115:547-555.
11. Ingwall, J. S., and R. G. Weiss. 2004. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ. Res. 95:135-145.
12. Kato, K., and S. Kimura. 1985. S100a0 (alpha alpha) protein is mainly located in the heart and striated muscles. Biochim. Biophys. Acta 842: 146-150.
13. Lehninger, A. L. 1967. Energy coupling in electron transport. Fed. Proc. 26:1333-1334.
14. Maeo, B., A. Mandinova, M. B. Durrenberger, B. W. Schafer, B. Uhrik, and C. W. Heizmann. 2001. Ultrastructural distribution of the S100A1 Ca2+-binding protein in the human heart. Physiol. Res. 50:567-574.
15. Most, P., J. Bernotat, P. Ehlermann, S. T. Pleger, M. Reppel, M. Borries, F. Niroomand, B. Pieske, P. M. Janssen, T. Eschenhagen, P. Karczewski, G. L. Smith, W. J. Koch, H. A. Katus, and A. Remppis. 2001. S100A1: a regulator of myocardial contractility. Proc. Natl. Acad. Sci. USA 98:13889-13894.
16. Most, P., M. Boerries, C. Eicher, C. Schweda, P. Ehlermann, S. T. Pleger, E. Loeffler, W. J. Koch, H. A. Katus, C. A. Sehoenenberger, and A. Remppis. 2003. Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2). J. Biol. Chem. 278:48404-48412.
17. Most, P., M. Ifoerries, C. Either, C. Schweda, M. Volkers, T. Wedel, S. Sollner, H. A. Katus, A. Remppis, U. Aehi, W. J. Koch, and C. A. Sehuenenberger. 2005. Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes. J. Cell Sci. 118:421-431.
18. Most, P., and W. J. Koch. 2007. S100A1: a calcium-modulating inotropic prototype for future clinical heart failure therapy. Future Cardiol. 3:5-11.
19. Most, P., S. T. Pleger, M. Volkers, B. Heidt, M. Boerries, D. Weichenhan, E. Loffler, P. M. Janssen, A. D. Eckhart, J. Martini, M. L. Williams, H. A. Katus, A. Remppis, and W. J. Koch. 2004. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J. Clin. Investig. 114:1550-1563.
20. Most, P., A. Remppis, S. T. Pleger, E. Loffler, P. Ehlermann, J. Bernotat, C. Kleuss, J. Heierhorst, P. Ruiz, H. Witt, P. Karczewski, L. Mao, H. A. Roekman, S. J. Duncan, H. A. Katus, and W. J. Koch. 2003. Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J. Biol. Chem. 278:33809-33817.
21. Most, P., H. Seifert, E. Gao, H. Funakoshi, M. Volkers, J. Heierhorst, A. Remppis, S. T. Pleger, B. R. DeGeorge, Jr., A. D. Eckhart, A. M. Feldman, and W. J. Koch. 2006. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction. Circulation 114:1258-1268.'
22. Orriss, G. L., A. G. Leslie, K. Braig, and J. E. Walker. 1998. Bovine F1-ATPase covalently inhibited with 4-chloro-7-nitrobenzofurazan: the structure provides further support for a rotary catalytic mechanism. Structure 6:831-837.
23. Remppis, A., P. Most, E. Loffler, P. Ehlermann, J. Bernotat, S. Pleger, M. Borries, M. Reppel, J. Fischer, W. J. Koch, G. Smith, and H. A. Katus. 2002. The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytes. Basic Res. Cardiol. 97(Suppl. I):156-162.
24. Sambrano, G. R., I. Eraser, H. Han, Y. Ni, T. O'Connell, Z. Yan, and J. T. Stull. 2002. Navigating the signalling network in mouse cardiac myocytes. Nature 420:712-714.
25. Schoenenherger, C. A., S. Buchmeier, M. Boerries, R. Sutterlin, U. Aehi, and B. M. Jockusch, 2005. Conformation-specific antibodies reveal distinct actin structures in the nucleus and the cytoplasm. J. Struct. Biol. 152:157-168.
26. Simonian, A., J. Baudier, and K. G. Haglid. 1989. Modulation of ATPase activities in the central nervous system by the S-100 proteins. Neurochem. Res. 14:761-764.
27. Territo, P. R., S. A. French, M. C. Dunleavy, F. J. Evans, and R. S. Baluban. 2001. Calcium activation of heart mitochondrial oxidative phosphorylation: rapid kinetics of mVO2, NADH, and light scattering. J. Biol. Chem. 276:2586-2599.
28. Territo, P. R., V. K. Mootha, S. A. French, and R. S. Balaban. 2000. Ca(2+) activation of heart mitochondrial oxidative phosphorylation: role of the F(0)/F(1)-ATPase. Am. J. Physiol. Cell Physiol. 278:C423-C435.
29. Ventura-Clapier, R., A. Gamier, and V. Veksler. 2004. Energy metabolism in heart failure. J. Physiol. 555:1-13.
30. Zimmer, D. B., E. H. Cornwall, A. Landar, and W. Song. 1995. The S100 protein family: history, function, and expression. Brain Res. Bull. 37:417-429.
31. Zimmer, D. B., and J. G. Dubuisson. 1993. Identification of an S100 target protein: glycogen phosphorylase. Cell Calcium 14:323-332.
32. Zimmer, D. B., and L.J. Van Eldik. 1986. Identification of a molecular target for the calcium-modulated protein S100. Fructose- 1,6-bisphosphate aldolase. J. Biol. Chem. 261:11424-11428.